ログイン

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS
63問 • 2年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Minor Lipoproteins ARE

    Lipoprotein A /Lpa Intermediate Density Lipoprotein (IDL)

  • 2

    Lipoprotein A /Lpa _______ pre –B lipoprotein

    SINKING

  • 3

    It involved accumulation of plasma VLDL rich in cholesterol and chylomicrons remnants

    Familial Dysbetalipoproteinemia/ Type 3 Hyperlipoproteinemia

  • 4

    Reference value VLDL C/TAG ratio:

    0.2

  • 5

    composed primarily of cholesterol esters, phospholipids, and apolipoprotein (a) and Apo B100

    Lipoprotein A /Lpa

  • 6

    INDEPENDENT risk factor for atherosclerosis

    Lipoprotein A /Lpa

  • 7

    Abetalipoproteinemia a. defective ______synthesis

    APO B

  • 8

    Lipoprotein A /Lpa _____ risk factor for atherosclerosis

    INDEPENDENT

  • 9

    defective APO B synthesis

    Abetalipoproteinemia

  • 10

    VLDL, LDL, and Chylomicrons= ABSENT

    Abetalipoproteinemia

  • 11

    Lipoprotein A /Lpa IS similar to

    plasminogen

  • 12

    Elevated levels of Lp(a) are associated with

    increased risk for coronary heart disease, myocardial infarction, and cerebrovascular disease

  • 13

    = ARE ABSENTIN Abetalipoproteinemia

    VLDL, LDL, and Chylomicrons

  • 14

    – VLDL catabolic prod.

    Intermediate Density Lipoprotein (IDL)

  • 15

    defective APO B synthesis

    Abetalipoproteinemia

  • 16

    Abetalipoproteinemia defective APO B synthesis/?

    BASSEN KORNZHEIG

  • 17

    Intermediate Density Lipoprotein (IDL) – is catabolic prod. of?

    VLDL

  • 18

    Chole and TAG = low

    Abetalipoproteinemia

  • 19

    is a transitional form

    Intermediate Density Lipoprotein (IDL)

  • 20

    Abetalipoproteinemia Chole and TAG = ?

    low

  • 21

    (IDL) –Carry: endogenous __________and cholesterol esters

    TAG

  • 22

    apo –B deficiency

    Hypobetalipoproteinemia

  • 23

    (IDL) –apolipoproteins

    apolipoproteins B-100

  • 24

    LDL-chole and total cholesterol = low levels VLDL-chole and Total TAG =Low or normal

    Hypobetalipoproteinemia

  • 25

    Abnormal Lipoproteins

    Lipoprotein X B –VLDL (floating B lipoprotein)

  • 26

    increased IDL DSE

    TYPE III HYPERLIPOPROTENEMIA

  • 27

    Hypoalphalipoproteinemia: Severely elevated __________level and____ HDL level

    TAG; LOW

  • 28

    : Severely elevated TAG level and LOW HDL level

    Hypoalphalipoproteinemia

  • 29

    Specific and sensitive indicator of cholestasis

    Lipoprotein X

  • 30

    Tangier’s disease - _____________________due to mutation in the ABCA1

    COMPLETE ABSENCE OF HDL

  • 31

    Lipoprotein X Specific and sensitive indicator of

    cholestasis

  • 32

    Lipoprotein X deficiency

    OBSTRUCTIVE jaundice and LCAT deficiency

  • 33

    - COMPLETE ABSENCE OF HDL due to mutation in the ABCA1

    Tangier’s disease

  • 34

    Lecithin Cholesterol Acyl Transferase (LCAT) deficiency – ______ disease

    FISHEY

  • 35

    WHAT Abnormal Lipoproteins THAT HAS OBSTRUCTIVE jaundice and LCAT deficiency

    Lipoprotein X

  • 36

    “abnormally migrating B-VLDL”

    B –VLDL (floating B lipoprotein

  • 37

    WHAT deficiency – FISHEY disease

    Lecithin Cholesterol Acyl Transferase (LCAT)

  • 38

    B –VLDL (floating B lipoprotein IS ALSO CALLED

    “abnormally migrating B-VLDL”

  • 39

    - deficiency of the enzyme hexosaminidase A- Spingolipid accum.

    Tay –Sach’s Disease

  • 40

    Tay –Sach’s Disease - deficiency of the ? - Spingolipid accum.

    enzyme hexosaminidase A

  • 41

    B –VLDL (floating B lipoprotein) ALSO FOUND IN WHAT DISEASES?

    dysbetalipoproteinemia/ type 3-hyperlipoprotenenmia

  • 42

    Found in dysbetalipoproteinemia/ type 3-hyperlipoprotenenmia

    B –VLDL (floating B lipoprotein)

  • 43

    Associated to Coronary disease

    ALL EXCEPT 1

  • 44

    Eruptive xanthoma

    TYPE 1,3,5

  • 45

    Xanthelasma and Hypercholesterolemia

    TYPE 2

  • 46

    Pancreatitis

    TYPE 1 & 5

  • 47

    DOMINANT CARRIER OF CHOLESTEROL TO TISSUES

    VLDL AND LDL

  • 48

    Familial Hypercholesterolemia (Type 2a) a. Defective ____receptors

    LDL

  • 49

    Defective LDL receptors

    Familial Hypercholesterolemia (Type 2a)

  • 50

    WHAT TYPE: Chylomicrons

    1

  • 51

    WHAT TYPE: LDL

    2A

  • 52

    WHAT TYPE: LDL and VLDL

    2b

  • 53

    WHAT TYPE: IDL

    3

  • 54

    WHAT TYPE: VLDL

    4

  • 55

    WHAT TYPE: VLDL , Chylomicron

    5

  • 56

    Type 1

    Chylomicrons

  • 57

    Type 2a

    LDL

  • 58

    Type 2b

    LDL and VLDL

  • 59

    Type 3

    IDL

  • 60

    Type 4

    VLDL

  • 61

    Type 5

    VLDL, Chylomicron

  • 62

    TC and LDL C (2-3x above normal)

    Familial Hypercholesterolemia (Type 2a)

  • 63

    : a broad abnormal BAND between VLDL and LDL (B-VLDL)

    Familial Dysbetalipoproteinemia/ Type 3 Hyperlipoproteinemia

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Minor Lipoproteins ARE

    Lipoprotein A /Lpa Intermediate Density Lipoprotein (IDL)

  • 2

    Lipoprotein A /Lpa _______ pre –B lipoprotein

    SINKING

  • 3

    It involved accumulation of plasma VLDL rich in cholesterol and chylomicrons remnants

    Familial Dysbetalipoproteinemia/ Type 3 Hyperlipoproteinemia

  • 4

    Reference value VLDL C/TAG ratio:

    0.2

  • 5

    composed primarily of cholesterol esters, phospholipids, and apolipoprotein (a) and Apo B100

    Lipoprotein A /Lpa

  • 6

    INDEPENDENT risk factor for atherosclerosis

    Lipoprotein A /Lpa

  • 7

    Abetalipoproteinemia a. defective ______synthesis

    APO B

  • 8

    Lipoprotein A /Lpa _____ risk factor for atherosclerosis

    INDEPENDENT

  • 9

    defective APO B synthesis

    Abetalipoproteinemia

  • 10

    VLDL, LDL, and Chylomicrons= ABSENT

    Abetalipoproteinemia

  • 11

    Lipoprotein A /Lpa IS similar to

    plasminogen

  • 12

    Elevated levels of Lp(a) are associated with

    increased risk for coronary heart disease, myocardial infarction, and cerebrovascular disease

  • 13

    = ARE ABSENTIN Abetalipoproteinemia

    VLDL, LDL, and Chylomicrons

  • 14

    – VLDL catabolic prod.

    Intermediate Density Lipoprotein (IDL)

  • 15

    defective APO B synthesis

    Abetalipoproteinemia

  • 16

    Abetalipoproteinemia defective APO B synthesis/?

    BASSEN KORNZHEIG

  • 17

    Intermediate Density Lipoprotein (IDL) – is catabolic prod. of?

    VLDL

  • 18

    Chole and TAG = low

    Abetalipoproteinemia

  • 19

    is a transitional form

    Intermediate Density Lipoprotein (IDL)

  • 20

    Abetalipoproteinemia Chole and TAG = ?

    low

  • 21

    (IDL) –Carry: endogenous __________and cholesterol esters

    TAG

  • 22

    apo –B deficiency

    Hypobetalipoproteinemia

  • 23

    (IDL) –apolipoproteins

    apolipoproteins B-100

  • 24

    LDL-chole and total cholesterol = low levels VLDL-chole and Total TAG =Low or normal

    Hypobetalipoproteinemia

  • 25

    Abnormal Lipoproteins

    Lipoprotein X B –VLDL (floating B lipoprotein)

  • 26

    increased IDL DSE

    TYPE III HYPERLIPOPROTENEMIA

  • 27

    Hypoalphalipoproteinemia: Severely elevated __________level and____ HDL level

    TAG; LOW

  • 28

    : Severely elevated TAG level and LOW HDL level

    Hypoalphalipoproteinemia

  • 29

    Specific and sensitive indicator of cholestasis

    Lipoprotein X

  • 30

    Tangier’s disease - _____________________due to mutation in the ABCA1

    COMPLETE ABSENCE OF HDL

  • 31

    Lipoprotein X Specific and sensitive indicator of

    cholestasis

  • 32

    Lipoprotein X deficiency

    OBSTRUCTIVE jaundice and LCAT deficiency

  • 33

    - COMPLETE ABSENCE OF HDL due to mutation in the ABCA1

    Tangier’s disease

  • 34

    Lecithin Cholesterol Acyl Transferase (LCAT) deficiency – ______ disease

    FISHEY

  • 35

    WHAT Abnormal Lipoproteins THAT HAS OBSTRUCTIVE jaundice and LCAT deficiency

    Lipoprotein X

  • 36

    “abnormally migrating B-VLDL”

    B –VLDL (floating B lipoprotein

  • 37

    WHAT deficiency – FISHEY disease

    Lecithin Cholesterol Acyl Transferase (LCAT)

  • 38

    B –VLDL (floating B lipoprotein IS ALSO CALLED

    “abnormally migrating B-VLDL”

  • 39

    - deficiency of the enzyme hexosaminidase A- Spingolipid accum.

    Tay –Sach’s Disease

  • 40

    Tay –Sach’s Disease - deficiency of the ? - Spingolipid accum.

    enzyme hexosaminidase A

  • 41

    B –VLDL (floating B lipoprotein) ALSO FOUND IN WHAT DISEASES?

    dysbetalipoproteinemia/ type 3-hyperlipoprotenenmia

  • 42

    Found in dysbetalipoproteinemia/ type 3-hyperlipoprotenenmia

    B –VLDL (floating B lipoprotein)

  • 43

    Associated to Coronary disease

    ALL EXCEPT 1

  • 44

    Eruptive xanthoma

    TYPE 1,3,5

  • 45

    Xanthelasma and Hypercholesterolemia

    TYPE 2

  • 46

    Pancreatitis

    TYPE 1 & 5

  • 47

    DOMINANT CARRIER OF CHOLESTEROL TO TISSUES

    VLDL AND LDL

  • 48

    Familial Hypercholesterolemia (Type 2a) a. Defective ____receptors

    LDL

  • 49

    Defective LDL receptors

    Familial Hypercholesterolemia (Type 2a)

  • 50

    WHAT TYPE: Chylomicrons

    1

  • 51

    WHAT TYPE: LDL

    2A

  • 52

    WHAT TYPE: LDL and VLDL

    2b

  • 53

    WHAT TYPE: IDL

    3

  • 54

    WHAT TYPE: VLDL

    4

  • 55

    WHAT TYPE: VLDL , Chylomicron

    5

  • 56

    Type 1

    Chylomicrons

  • 57

    Type 2a

    LDL

  • 58

    Type 2b

    LDL and VLDL

  • 59

    Type 3

    IDL

  • 60

    Type 4

    VLDL

  • 61

    Type 5

    VLDL, Chylomicron

  • 62

    TC and LDL C (2-3x above normal)

    Familial Hypercholesterolemia (Type 2a)

  • 63

    : a broad abnormal BAND between VLDL and LDL (B-VLDL)

    Familial Dysbetalipoproteinemia/ Type 3 Hyperlipoproteinemia